Food and Drug Administration

Oncologic Drugs Advisory Committee

July 27, 2004

Briefing Information

Eli Lilly and Company Briefing Document (PDF)

Introduction Memorandum, FDA (HTM) (PDF) (Word)

FDA Briefing Document - Clinical (HTM) (PDF) (Word)

Statistical Review and Evalution, FDA (PDF)

Corrections in FDA Clinical Briefing Materials (PDF)

Statistical Review Addendum #1 (PDF)